CVS Health Co. (NYSE:CVS) Shares Sold by Marco Investment Management LLC

Marco Investment Management LLC trimmed its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 8.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 145,198 shares of the pharmacy operator's stock after selling 13,460 shares during the quarter. Marco Investment Management LLC's holdings in CVS Health were worth $11,465,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CVS. Atticus Wealth Management LLC boosted its holdings in CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator's stock valued at $29,000 after purchasing an additional 219 shares during the period. Cornerstone Planning Group LLC increased its stake in shares of CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator's stock worth $32,000 after buying an additional 243 shares during the period. ZRC Wealth Management LLC raised its holdings in CVS Health by 400.0% in the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator's stock valued at $39,000 after acquiring an additional 400 shares in the last quarter. Coston McIsaac & Partners grew its holdings in CVS Health by 42.6% during the 4th quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator's stock worth $42,000 after acquiring an additional 161 shares in the last quarter. Finally, Tennessee Valley Asset Management Partners purchased a new stake in shares of CVS Health in the 4th quarter valued at approximately $50,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Performance

CVS Health stock traded down $0.15 during mid-day trading on Friday, reaching $67.18. 6,396,438 shares of the company were exchanged, compared to its average volume of 8,376,818. The firm has a market cap of $84.68 billion, a PE ratio of 10.40, a price-to-earnings-growth ratio of 0.89 and a beta of 0.52. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86. The firm's 50-day simple moving average is $74.42 and its two-hundred day simple moving average is $73.67. CVS Health Co. has a twelve month low of $64.41 and a twelve month high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.11. The company had revenue of $93.81 billion for the quarter, compared to analysts' expectations of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. CVS Health's revenue was up 11.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.99 EPS. Equities analysts predict that CVS Health Co. will post 8.31 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.96%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health's payout ratio is 41.18%.

Insider Activity

In related news, EVP Prem S. Shah sold 29,473 shares of the company's stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares of the company's stock, valued at $3,059,916.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.24% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Cantor Fitzgerald reiterated an "overweight" rating and set a $87.00 target price on shares of CVS Health in a research note on Wednesday, April 10th. Royal Bank of Canada cut their target price on CVS Health from $86.00 to $84.00 and set an "outperform" rating on the stock in a research report on Thursday, February 8th. Leerink Partnrs reaffirmed an "outperform" rating on shares of CVS Health in a report on Monday, February 26th. Piper Sandler raised their price objective on shares of CVS Health from $93.00 to $94.00 and gave the stock an "overweight" rating in a report on Friday, March 15th. Finally, SVB Leerink started coverage on shares of CVS Health in a report on Monday, February 26th. They issued an "outperform" rating and a $88.00 target price for the company. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $89.44.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.